Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses

Heather K Knych, Scott D Stanley, Linda M. Harrison, Daniel S. Mckemie

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The use of corticosteroids, such as betamethasone, in performance horses is tightly regulated. The objective of the current study was to describe the plasma pharmacokinetics of betamethasone as well as time-related urine and synovial fluid concentrations following intra-articular administration to horses. Twelve racing-fit adult Thoroughbred horses received a single intra-articular administration (9 mg) of a betamethasone sodium phosphate and betamethasone acetate injectable suspension into the right antebrachiocarpal joint. Blood, urine, and synovial fluid samples were collected prior to and at various times up to 21 days post drug administration. All samples were analyzed using tandem liquid chromatography-mass spectrometry. Plasma data were analyzed using compartmental pharmacokinetic modeling. Maximum measured plasma betamethasone concentrations were 3.97 ± 0.23 ng/mL at 1.45 ± 0.20 h. The plasma elimination half-life was 7.48 ± 0.39 h. Betamethasone concentrations were below the limit of detection in all horses by 96 h and 7 days in plasma and urine, respectively. Betamethasone fell below the limit of detection in the right antebrachiocarpal joint between 14 and 21 days. Results of this study provide information that can be used to regulate the use of intra-articular betamethasone in the horse.

Original languageEnglish (US)
Pages (from-to)1385-1391
Number of pages7
JournalDrug Testing and Analysis
Volume9
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Betamethasone
Pharmacokinetics
Synovial Fluid
horse
urine
Horses
Joints
Urine
Plasmas
plasma
Fluids
fluid
Limit of Detection
Sodium Acetate
half life
Liquid chromatography
liquid chromatography
acetate
drug
Liquid Chromatography

Keywords

  • betamethasone
  • corticosteroid
  • horse
  • horse racing
  • Inflammation; pharmacokinetics
  • intra-articular

ASJC Scopus subject areas

  • Analytical Chemistry
  • Environmental Chemistry
  • Pharmaceutical Science
  • Spectroscopy

Cite this

Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses. / Knych, Heather K; Stanley, Scott D; Harrison, Linda M.; Mckemie, Daniel S.

In: Drug Testing and Analysis, Vol. 9, No. 9, 01.09.2017, p. 1385-1391.

Research output: Contribution to journalArticle

@article{a9b9216c73074808a7bbb41181a1fe79,
title = "Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses",
abstract = "The use of corticosteroids, such as betamethasone, in performance horses is tightly regulated. The objective of the current study was to describe the plasma pharmacokinetics of betamethasone as well as time-related urine and synovial fluid concentrations following intra-articular administration to horses. Twelve racing-fit adult Thoroughbred horses received a single intra-articular administration (9 mg) of a betamethasone sodium phosphate and betamethasone acetate injectable suspension into the right antebrachiocarpal joint. Blood, urine, and synovial fluid samples were collected prior to and at various times up to 21 days post drug administration. All samples were analyzed using tandem liquid chromatography-mass spectrometry. Plasma data were analyzed using compartmental pharmacokinetic modeling. Maximum measured plasma betamethasone concentrations were 3.97 ± 0.23 ng/mL at 1.45 ± 0.20 h. The plasma elimination half-life was 7.48 ± 0.39 h. Betamethasone concentrations were below the limit of detection in all horses by 96 h and 7 days in plasma and urine, respectively. Betamethasone fell below the limit of detection in the right antebrachiocarpal joint between 14 and 21 days. Results of this study provide information that can be used to regulate the use of intra-articular betamethasone in the horse.",
keywords = "betamethasone, corticosteroid, horse, horse racing, Inflammation; pharmacokinetics, intra-articular",
author = "Knych, {Heather K} and Stanley, {Scott D} and Harrison, {Linda M.} and Mckemie, {Daniel S.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1002/dta.2170",
language = "English (US)",
volume = "9",
pages = "1385--1391",
journal = "Drug Testing and Analysis",
issn = "1942-7603",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

TY - JOUR

T1 - Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses

AU - Knych, Heather K

AU - Stanley, Scott D

AU - Harrison, Linda M.

AU - Mckemie, Daniel S.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The use of corticosteroids, such as betamethasone, in performance horses is tightly regulated. The objective of the current study was to describe the plasma pharmacokinetics of betamethasone as well as time-related urine and synovial fluid concentrations following intra-articular administration to horses. Twelve racing-fit adult Thoroughbred horses received a single intra-articular administration (9 mg) of a betamethasone sodium phosphate and betamethasone acetate injectable suspension into the right antebrachiocarpal joint. Blood, urine, and synovial fluid samples were collected prior to and at various times up to 21 days post drug administration. All samples were analyzed using tandem liquid chromatography-mass spectrometry. Plasma data were analyzed using compartmental pharmacokinetic modeling. Maximum measured plasma betamethasone concentrations were 3.97 ± 0.23 ng/mL at 1.45 ± 0.20 h. The plasma elimination half-life was 7.48 ± 0.39 h. Betamethasone concentrations were below the limit of detection in all horses by 96 h and 7 days in plasma and urine, respectively. Betamethasone fell below the limit of detection in the right antebrachiocarpal joint between 14 and 21 days. Results of this study provide information that can be used to regulate the use of intra-articular betamethasone in the horse.

AB - The use of corticosteroids, such as betamethasone, in performance horses is tightly regulated. The objective of the current study was to describe the plasma pharmacokinetics of betamethasone as well as time-related urine and synovial fluid concentrations following intra-articular administration to horses. Twelve racing-fit adult Thoroughbred horses received a single intra-articular administration (9 mg) of a betamethasone sodium phosphate and betamethasone acetate injectable suspension into the right antebrachiocarpal joint. Blood, urine, and synovial fluid samples were collected prior to and at various times up to 21 days post drug administration. All samples were analyzed using tandem liquid chromatography-mass spectrometry. Plasma data were analyzed using compartmental pharmacokinetic modeling. Maximum measured plasma betamethasone concentrations were 3.97 ± 0.23 ng/mL at 1.45 ± 0.20 h. The plasma elimination half-life was 7.48 ± 0.39 h. Betamethasone concentrations were below the limit of detection in all horses by 96 h and 7 days in plasma and urine, respectively. Betamethasone fell below the limit of detection in the right antebrachiocarpal joint between 14 and 21 days. Results of this study provide information that can be used to regulate the use of intra-articular betamethasone in the horse.

KW - betamethasone

KW - corticosteroid

KW - horse

KW - horse racing

KW - Inflammation; pharmacokinetics

KW - intra-articular

UR - http://www.scopus.com/inward/record.url?scp=85030117823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030117823&partnerID=8YFLogxK

U2 - 10.1002/dta.2170

DO - 10.1002/dta.2170

M3 - Article

VL - 9

SP - 1385

EP - 1391

JO - Drug Testing and Analysis

JF - Drug Testing and Analysis

SN - 1942-7603

IS - 9

ER -